Effect of Inflammatory Bowel Disease on sexual function in men and women: A controlled study

Effect of Inflammatory Bowel Disease on sexual function in men and women: A controlled study - Effect of Inflammatory Bowel Disease on sexual function

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38172

Enrollment

1500

Registered

2011-07-11

Start date

2012-03-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual complaints sexual problems

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients will be eligible for inclusion if they 1) are >= 18 and

Exclusion criteria

Exclusion criteria: 1) have no diseases other than diseases secondary to IBD

Design outcomes

Primary

Measure	Time frame
Sexual functioning as measured with validated questionnaires. The International Index of Erectile Function (IIEF) will be used in the male participants, and the Female Sexual Function Index (FSFI) in the female participants	—

Secondary

Measure	Time frame
Depression as measured with a validated questionnaire (the Hospital Anxiety and Depression Scale, HADS). Disease-specific quality of life (measured with the S-IBDQ,), Disease activity (as measured with the The Harvey Bradshaw Index (for Crohns disease) and the Simple Clinical Colitis Activity Index SSCAI (for ulcerative colitis), Body image (as measured with the EORTC-QLQ-CR 38). From the medical records of the IBD patients the following data will be retrieved: classification of Crohns disease or ulcerative colitis (Montreal Classification) duration of the disease, use of medication (corticosteroids), co-morbidities, and operations.	—

Measure

Time frame

Depression as measured with a validated questionnaire (the Hospital Anxiety and Depression Scale, HADS). Disease-specific quality of life (measured with the S-IBDQ,), Disease activity (as measured with the The Harvey Bradshaw Index (for Crohn*s disease) and the Simple Clinical Colitis Activity Index SSCAI (for ulcerative colitis), Body image (as measured with the EORTC-QLQ-CR 38). From the medical records of the IBD patients the following data will be retrieved: classification of Crohn*s disease or ulcerative colitis (Montreal Classification) duration of the disease, use of medication (corticosteroids), co-morbidities, and operations.

—

Countries

Netherlands

Outcome results